Amanda Armond
Women's Health · Austin, TXNPI 1285094060
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Astellas Pharma US Inc accounts for 85.5% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $14,384 and has fallen 98.3% since, to $242 in 2025. Among women's health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $241.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$14K
- AbbVie$289
- Gilead$247
- Amgen$244
- Avion Pharmaceuticals$232
- Inspire Medical Systems, Inc.$143
- plus $1K from 18 others
What the payments were for
- Consulting fees$3,05918%
- Speaking & faculty fees$7,82047%
- Travel & lodging$2,27414%
- Food & beverage$3,53521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 29 | $14,268 |
| AbbVie | 6 | $289 |
| Gilead | 2 | $247 |
| Amgen | 2 | $244 |
| Avion Pharmaceuticals | 2 | $232 |
| Inspire Medical Systems, Inc. | 1 | $143 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $122 |
| Mannkind Corporation | 1 | $120 |
| Hologic Sales And Service, LLC | 2 | $119 |
| GSK | 1 | $119 |
| Sanofi | 1 | $116 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $96 |
| Genentech USA, Inc. | 1 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $63 |
| Astellas Pharma Global Development | 2 | $59 |
| Exeltis, USA Inc. | 3 | $48 |
| Acessa Health Inc. | 1 | $45 |
| Avanos Medical | 3 | $45 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Myovant Sciences Inc. | 1 | $25 |
| Boston Scientific | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Davol Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,688 in reported general payments places this provider in the 95th percentile of 609 women's health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $422 |
Paid to pharmacies, not to this prescriber.
Other women's health in Austin
- Casey FriesenhahnAustin$5K
- Kelly ReaganAustin$4K
- Madison WebbAustin$4K
- Gretchen PalmerAustin$3K
- Jenna CarneyAustin$3K
- Regan McFaulAustin$3K
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Shelagh LarsonFort Worth$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.